However, it was observed that anti-sp100 was a distinctive risk factor that had a statistically significant association with adverse outcomes, but only in the PBC plus hypertension group (Figure 4) (P=0.013, HR: 2.686, 95% CI:1.230–5.868). This evidence concerns the gene SP100 and hypertensive disorder.